SubjectWell acquires PatientCentra, boosting rare disease/oncology recruitment

SubjectWell, a platform connecting individuals with chronic health conditions to healthcare options, has successfully acquired PatientCentra, a company specialising in global patient recruitment and personalised recruitment journeys. 

While the financial terms of the deal remain undisclosed, this strategic acquisition significantly bolsters SubjectWell's ability to meet patient recruitment requirements for international clinical studies. It also expands its capabilities in recruiting for rare diseases and oncology-related research.

The amalgamation of SubjectWell and PatientCentra's resources now allows clients to access comprehensive, global patient recruitment support from a single entity. This support covers a wide spectrum of studies, including vaccine trials, chronic conditions, rare diseases, and oncology research.

PatientCentra, headquartered in Waltham, MA, is known for its full-service global patient recruitment capabilities and its in-house agency, which specialises in crafting customised, patient-centred recruitment journeys. 

With 15 years of experience in delivering digitally enabled patient recruitment programs across five continents, PatientCentra's expertise complements SubjectWell's existing strengths in North America.